These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19953465)

  • 1. [Medication associated long QT syndrome].
    Bruggisser M; Rätz Bravo A; Bodmer M
    Praxis (Bern 1994); 2009 Dec; 98(24):1409-15; quiz 1415. PubMed ID: 19953465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes induced by citalopram and amiodarone.
    Fayssoil A; Issi J; Guerbaa M; Raynaud JC; Heroguelle V
    Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):165-8. PubMed ID: 21295285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.
    de Gregorio C; Morabito G; Cerrito M; Dattilo G; Oreto G
    Int J Cardiol; 2011 Apr; 148(2):226-8. PubMed ID: 19540606
    [No Abstract]   [Full Text] [Related]  

  • 5. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study.
    Girardin FR; Gex-Fabry M; Berney P; Shah D; Gaspoz JM; Dayer P
    Am J Psychiatry; 2013 Dec; 170(12):1468-76. PubMed ID: 24306340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Citalopram and Torsades de Pointes. A case report].
    Meuleman C; Jourdain P; Bellorini M; Sadeg N; Loiret J; Guillard N; Thebault B; Funck F
    Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1021-4. PubMed ID: 11603066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case report.
    Adetunji B; Basil B; Mathews M; Osinowo T
    J Clin Psychopharmacol; 2006 Aug; 26(4):438. PubMed ID: 16855470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
    Tseng PT; Lee Y; Lin YE; Lin PY
    Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long QT syndrome due to olanzapine administration].
    Janion M; Dudek A; Sielski J; Janion-Sadowska A
    Kardiol Pol; 2006 Sep; 64(9):986-8. PubMed ID: 17054030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsade de pointes during combined treatment with risperidone and citalopram.
    Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W
    Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657
    [No Abstract]   [Full Text] [Related]  

  • 15. [QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
    Züchner H
    Dtsch Med Wochenschr; 2002 May; 127(18):983-4. PubMed ID: 11987023
    [No Abstract]   [Full Text] [Related]  

  • 16. Antidepressants and QTc prolongation.
    Lam RW
    J Psychiatry Neurosci; 2013 Mar; 38(2):E5-6. PubMed ID: 23422053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C; Canceil O; Iaria P
    Encephale; 2000; 26(6):62-72. PubMed ID: 11217540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram-induced diplopia.
    Dorell K; Cohen MA; Huprikar SS; Gorman JM; Jones M
    Psychosomatics; 2005; 46(1):91-3. PubMed ID: 15765832
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine.
    Letsas KP; Sideris A; Kounas SP; Efremidis M; Korantzopoulos P; Kardaras F
    Int J Cardiol; 2006 May; 109(2):273-4. PubMed ID: 15935493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes caused by citalopram during the pacemaker battery-depletion phase: A case report.
    Wang J; Sun Z; Tao S
    Ann Noninvasive Electrocardiol; 2022 Jul; 27(4):e12936. PubMed ID: 35322503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.